Altimmune News and Activities

Presence

Altimmune is a biopharmaceutical company that develops treatments for obesity, liver disease, and immune-related conditions. Its products and research services target patients, healthcare providers, and pharmaceutical partners.

Altimmune products and services overview:

Obesity treatments
Liver disease therapies
Immunotherapy research
Drug development

Revenue: ~$5 million

Employees: 60

Headquarters: Gaithersburg, United States (USA)

Altimmune is one of the...

Altimmune is a company listed under the stock ticker ALT (US).

Acquisition, funding and merger involving Altimmune.

Altimmune has just announced a $225 Million fundraising (posted on April 27 2026).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at Altimmune

Popular executive movements at Altimmune

Vipin Garg, Director, President and Chief Executive Officer, will leave the company on Jan. 1, 2026 (posted on December 1 2025).
Jerry Durso who is Chairman of the Board, will become President, Chief Executive Officer and Chairman of the Board on Jan. 1, 2026 (posted on December 1 2025).
Christophe Arbet-Engels has joined the company as Chief Medical Officer (posted on October 1 2025).

Click here to view some more movements at Altimmune

Create your alert
to follow the executive moves at Altimmune.